肝门部胆管癌32例的治疗分析 |
| |
引用本文: | 梁旭东,杜焕社,史晓锋.肝门部胆管癌32例的治疗分析[J].中国医药,2009,4(8):900-902. |
| |
作者姓名: | 梁旭东 杜焕社 史晓锋 |
| |
作者单位: | 河南科技大学第二附属医院普通外科,河南省洛阳市,471000; |
| |
摘 要: | 目的 分析肝门部胆管癌的治疗方法.方法 回顾性分析1998年4月至2007年12月32例肝门部胆管癌患者的治疗情况.结果 剖腹探查取活检7例(21.9%),平均存活时间为54 d.单纯胆管引流7例(21.9%),平均存活时间为5.6个月.手术切除加吻合18例(56.3%),平均存活时间为18.3个月.结论 影像学检查在肝门部胆管癌的诊断中具有重要价值;外科手术是治疗肝门部胆管癌最有效的方法;胆道引流亦可延长患者生存期;综合治疗是肝门部胆管癌治疗的方向.
|
关 键 词: | 胆管癌 胆道引流 |
Therapy of 32 cases of hepatic portal cholangiocarcinoma |
| |
Abstract: | Objective To observe surgical therapies of hepatic portal cholangiocarcinoma. Methods Thir-ty-two cases of hepatic portal cholangiocarcinoma between April 1998 and December 2007 were analyzed retrospec-tively. Results Average survival time of 7 cases (21.9%) of paunch ascertainment biopsy was 54 days. Average survival time of 7 cases(21.9%) of simplicity bile duct drainage was 5.6 months. Meanwhile average survival time of 18 cases (56.3%) of surgery excision and anastomosis were 18.3 months. Conclusions Image examination is of important value in diagnoses of hilar cholangiocarcinoma. Surgery is the primary method to treat hilar cholangiocarci-noma. Bile duct drainage may prolang patient's survival time and Iintegrative therapy is a direction of treating hilar cholangiocarcinoma. |
| |
Keywords: | CholangiocarcinomaBile duct drainage |
|